These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1715121)

  • 21. Reply to Proper observation of patient related factors is an important determinant in the utility of the D-dimer test for exclusion of venous thromboembolism in the ED.
    Ray P
    Am J Emerg Med; 2007 May; 25(4):485-6. PubMed ID: 17499677
    [No Abstract]   [Full Text] [Related]  

  • 22. Five steps for the use and interpretation of D-dimer in the Emergency Department.
    Gesu E; Maria Rusconi A; Ceriani E
    Intern Emerg Med; 2019 Mar; 14(2):311-314. PubMed ID: 30730033
    [No Abstract]   [Full Text] [Related]  

  • 23. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of human thrombi in the rabbit jugular vein: I: Comparison of two fibrin-specific monoclonal antibodies.
    Tymkewycz PM; Creighton LJ; Gascoine PS; Zanelli GD; Webbon PM; Gaffney PJ
    Thromb Res; 1989 Jun; 54(5):411-21. PubMed ID: 2772866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay of fibrinogen-fibrin degradation products: assay for fragment E-related neoantigen-methodological aspects.
    Chen JP; Schulof RS
    Thromb Res; 1979; 16(5-6):601-15. PubMed ID: 93312
    [No Abstract]   [Full Text] [Related]  

  • 26. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality assurance in hemostasis. A European versus North American perspective.
    Kitchen S
    Lab Hematol; 2004; 10(3):175-7. PubMed ID: 15529441
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of indium-111-labeled anti-fibrin antibody for imaging vascular thrombi.
    Knight LC; Maurer AH; Ammar IA; Shealy DJ; Mattis JA
    J Nucl Med; 1988 Apr; 29(4):494-502. PubMed ID: 3351604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-dimer testing in suspected venous thromboembolism: an update.
    Bounameaux H; de Moerloose P; Perrier A; Miron MJ
    QJM; 1997 Jul; 90(7):437-42. PubMed ID: 9302426
    [No Abstract]   [Full Text] [Related]  

  • 30. D-dimer in venous thromboembolism.
    Bockenstedt P
    N Engl J Med; 2003 Sep; 349(13):1203-4. PubMed ID: 14507947
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain.
    Matsumoto T; Nishijima Y; Teramura Y; Fujino K; Hibino M; Hirata M
    Thromb Res; 1985 May; 38(3):297-302. PubMed ID: 2410999
    [No Abstract]   [Full Text] [Related]  

  • 33. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
    Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
    Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New perspectives in thrombus-specific imaging: radiolabeled monoclonal antibodies.
    Oster ZH; Som P
    AJR Am J Roentgenol; 1989 Feb; 152(2):253-60. PubMed ID: 2643259
    [No Abstract]   [Full Text] [Related]  

  • 35. Using new D-dimer tests to rule out venous thromboembolism.
    Sandrick K
    CAP Today; 2000 Feb; 14(2):40-2, 44, 46-7. PubMed ID: 10788296
    [No Abstract]   [Full Text] [Related]  

  • 36. Stratification of risk factors in venous thromboembolism: use of the D-dimer test.
    Sudoyo AW
    Acta Med Indones; 2005; 37(4):235-42. PubMed ID: 16317223
    [No Abstract]   [Full Text] [Related]  

  • 37. Monoclonal antibody immunoassay in the study of thrombogenicity of preclotted and gelatin-impregnated aortic prostheses.
    Zahrani HA; Cuschieri RJ; Lowe GD; Douglas JT; Pollock JG
    Ann Vasc Surg; 1989 Jul; 3(3):248-50. PubMed ID: 2673317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis.
    Rowbotham BJ; Carroll P; Whitaker AN; Bunce IH; Cobcroft RG; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ
    Thromb Haemost; 1987 Feb; 57(1):59-61. PubMed ID: 3590082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Falsely elevated D-dimer results in a healthy patient on account of heterophiletul antibodies.
    Gardiner C; Pennaneac'h C; Mackie IJ; Sheldrake A; Harrison J; Machin SJ
    Br J Haematol; 2003 Sep; 122(5):871-3. PubMed ID: 12930405
    [No Abstract]   [Full Text] [Related]  

  • 40. Antifibrin monoclonal antibody: its production, characterization and application in thrombus imaging.
    Liau CS
    Taiwan Yi Xue Hui Za Zhi; 1988 Mar; 87(3):339-45. PubMed ID: 3397730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.